Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 636, pseudogene (RNU6-636P) is a processed pseudogene related to the U6 small nuclear RNA (snRNA) gene family[4]. U6 snRNA is a highly conserved component of the spliceosome, a ribonucleoprotein complex essential for pre-mRNA splicing in eukaryotes[1][3]. However, RNU6-636P itself is a pseudogene, meaning it is a non-coding genetic element derived from the ancestral functional U6 gene, but lacks functional RNA output and is not involved in active cellular or therapeutic processes[4][5]. Human genomes contain many U6 snRNA pseudogenes, reflecting the evolutionary significance and high conservation of the original U6 gene[3][5]. There are no known roles for RNU6-636P in disease, therapy, or as a biomarker or drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 636, pseudogene (RNU6-636P).